分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

天眼查资料显示，中原内配成立于1996年12月29日，注册资本58840.9646万人民币，法定代表人薛亚辉，注册地址为河南省孟州市产业集聚区淮河大道69 号。主营业务为汽车核心零部件产品的研发、生产和销售。 目前，公司董事长为薛亚辉，董秘为李培，员工人数为5686人，实际控制人为薛德龙。 公司参股公司31家，包括Incodel Holding LLC、ZYNP Group （U.S.A） Inc.、ZYNP Asset Management LLC、开封同声氢能科技有限公司、中原内配（欧 洲）有限责任公司等。 在业绩方面，公司2022年、2023年、2024年和2025年前三季度营业收入分别为23.02亿元、28.64亿元、33.10亿元和28.67亿元，同比分别增长-6.01%、 24.45%、15.57%和16.35%。归母净利润分别为1.67亿元、3.11亿元、2.04亿元和3.26亿元，归母净利润同比增长分别为-20.82%、85.75%、-34.37%和 39.89%。同期，公司资产负债率分别为35.06%、34.32%、32.69%和31.59%。 在风险方面，天眼查信息显示，公司自身天眼风险2 ...

Investment Overview - Company plans to acquire a partnership interest in the Henan Aerospace Industry Fund for a nominal price of 0 yuan, corresponding to a subscribed capital of 50 million yuan [1] - The transaction does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations, and does not require approval from regulatory authorities [1][2] - The investment decision falls within the authority of the chairman and does not require board or shareholder approval [1] Henan Aerospace Industry Fund Overview - The Henan Aerospace Industry Fund was established on September 6, 2025, with a total subscribed capital of 2 billion yuan [2][3] - The fund is managed by Shenzhen Guoyu Gao Hua Investment Management Co., Ltd., and is registered as a private equity fund [4][9] - As of now, the fund has received 281 million yuan in actual contributions from its partners [3] Transaction Details - The transferor of the partnership interest is Jiaozuo Tongcai Innovation and Entrepreneurship Investment Fund, which will transfer a total of 50 million yuan in unpaid capital to the company [5][29] - The transfer does not involve any related party relationships or interests between the company and the transferor [5][6] - The transaction includes a total of 10 million yuan in unpaid capital being transferred to the company, with the remaining amounts allocated to other parties [30][31] Partnership Agreement Highlights - The partnership agreement aims to create satisfactory investment returns through equity investments in target companies [37] - The fund has a total subscribed capital of 2 billion yuan, with an investment period of seven years and a possible extension of up to two years [38][39] - The fund will primarily invest in the aerospace industry, focusing on rockets, satellite materials, and components [42] Financial and Operational Impact - The investment is intended to enhance the company's resource integration capabilities and optimize asset allocation without impacting its main business operations [49] - The funding for this investment will come from the company's own or raised funds, ensuring no adverse effects on the company's financial status [49] - The company will not have control over the Henan Aerospace Industry Fund, as it will only hold a limited partnership interest [50]

人民财讯11月24日电，中原内配(002448)11月24日公告，公司拟以0元价格受让焦作通财持有的河南空 天产业基金对应认缴出资5000万元(实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基 金其他合伙人签订合伙协议，履行出资义务。河南空天产业基金于2025年9月6日成立。截至目前，河南 空天产业基金合伙人已实缴出资2.81亿元。 ...

格隆汇11月24日丨中原内配(002448.SZ)公布，为进一步提升公司资源整合能力，优化资产配置， 中原内配集团股份有限公司拟以0元价格受让焦作通财创新创业投资基金(有限合伙)(简称"焦作通财")持 有的河南空天产业基金合伙企业(有限合伙)(简称"河南空天产业基金"或"合伙企业")对应认缴出资 5,000.00万元(实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基金其他合伙人签订合伙 协议，履行出资义务。 ...

中原内配(002448.SZ)公告，公司拟以0元价格受让焦作通财创新创业投资基金(有限合伙)(简称"焦作通 财")持有的河南空天产业基金合伙企业(有限合伙)(简称"河南空天产业基金")对应认缴出资5000.00万元 (实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基金其他合伙人签订合伙协议，履行 出资义务。 ...

智通财经APP讯，中原内配(002448.SZ)公告，公司拟以0元价格受让焦作通财创新创业投资基金(有限合 伙)(简称"焦作通财")持有的河南空天产业基金合伙企业(有限合伙)(简称"河南空天产业基金")对应认缴 出资5000.00万元(实缴出资额0元)的合伙份额，并作为有限合伙人与河南空天产业基金其他合伙人签订 合伙协议，履行出资义务。 ...

证券代码：002448 证券简称：中原内配 公告编号：2025-044 中原内配集团股份有限公司 关于受让河南空天产业基金合伙企业（有限合伙）份额 暨对外投资的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、对外投资概述 为进一步提升公司资源整合能力，优化资产配置，中原内配集团股份有限公 司（以下简称"公司"）拟以 0 元价格受让焦作通财创新创业投资基金（有限合 伙）（以下简称"焦作通财"）持有的河南空天产业基金合伙企业（有限合伙） （以下简称"河南空天产业基金"或"合伙企业"）对应认缴出资 5,000.00 万 元（实缴出资额 0 元）的合伙份额（以下简称"标的份额"或"合伙份额"）， 并作为有限合伙人与河南空天产业基金其他合伙人签订合伙协议，履行出资义务。 本次交易不构成关联交易，也不构成《上市公司重大资产重组管理办法》规 定的重大资产重组情形，无需有关部门批准。 根据《公司章程》《深圳证券交易所上市公司自律监管指引第 7 号——交易 与关联交易》等相关规定，本次投资事项在董事长审议权限范围，无需经董事会 或股东会审议。 二、河南空天产业基金的基本情 ...

中原内配公告，公司拟以0元价格受让焦作通财创新创业投资基金（有限合伙）持有的河南空天产业基 金合伙企业（有限合伙）对应认缴出资5000万元（实缴出资额0元）的合伙份额，并作为有限合伙人与 河南空天产业基金其他合伙人签订合伙协议，履行出资义务。本次交易不构成关联交易，也不构成《上 市公司重大资产重组管理办法》规定的重大资产重组情形，无需有关部门批准。 ...

证券日报网讯中原内配（002448）11月24日在互动平台回答投资者提问时表示，截至2025年11月20日收 盘，公司股东户数为48043户。 ...